Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biofrontera (BFRI)
NASDAQ:BFRI
Biofrontera (BFRI) Stock Price & Analysis
94 Followers
BFRI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.61 - $13.42
Previous Close$2.09
Volume78.67K
Average Volume (3M)790.89K
Market Cap
$10.18M
Enterprise Value$14.69M
Total Cash (Recent Filing)$1.34M
Total Debt (Recent Filing)$5.40M
Price to Earnings (P/E)-0.1
Beta0.80
Next Earnings
May 10, 2024EPS Estimate
-$1.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.82
Shares Outstanding5,089,413
10 Day Avg. Volume209,694
30 Day Avg. Volume790,887
Standard Deviation0.28
R-Squared0.03
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)5.60
Price to Sales (P/S)0.96
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.38
Enterprise Value/Gross Profit0.86
Enterprise Value/Ebitda-0.96
Forecast
1Y Price Target
$16.00Price Target Upside665.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Biofrontera News
PremiumCompany Announcements
Biofrontera Raises $8M for Development and Corporate Growth
PremiumCompany Announcements
Biofrontera Announces Key Agreements and $8M Funding Boost
PremiumCompany Announcements
Biofrontera Initiates Prompt Ameluz® Recall Over Packaging Defects
PremiumCompany Announcements
Biofrontera FDA Review Advances Ameluz® Dosage Expansion
Options Prices
Currently, No data available
---
Ownership Overview
6.72%
Insiders
0.39% Mutual Funds
0.17% Other Institutional Investors
92.73% Public Companies and
Individual Investors
BFRI FAQ
What was Biofrontera’s price range in the past 12 months?
Biofrontera lowest stock price was $0.61 and its highest was $13.42 in the past 12 months.
What is Biofrontera’s market cap?
Currently, no data Available
When is Biofrontera’s upcoming earnings report date?
Biofrontera’s upcoming earnings report date is May 10, 2024 which is in 25 days.
How were Biofrontera’s earnings last quarter?
Biofrontera released its earnings results on Mar 15, 2024. The company reported $4.45 earnings per share for the quarter, beating the consensus estimate of -$1.19 by $5.64.
Is Biofrontera overvalued?
According to Wall Street analysts Biofrontera’s price is currently Undervalued.
Does Biofrontera pay dividends?
Biofrontera does not currently pay dividends.
What is Biofrontera’s EPS estimate?
Biofrontera’s EPS estimate is -$1.17.
How many shares outstanding does Biofrontera have?
Biofrontera has 5,089,413 shares outstanding.
What happened to Biofrontera’s price movement after its last earnings report?
Biofrontera reported an EPS of $4.45 in its last earnings report, beating expectations of -$1.19. Following the earnings report the stock price went down -18.71%.
Which hedge fund is a major shareholder of Biofrontera?
Currently, no hedge funds are holding shares in BFRI
---
Biofrontera Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.00 (665.55% Upside)
$16.00 (665.55% Upside)
Blogger Sentiment
Bullish
BFRI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 3.5%
Last 30 Days ▼ 3.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.43%
12-Months-Change
Fundamentals
Return on Equity
-140.43%
Trailing 12-Months
Asset Growth
-45.11%
Trailing 12-Months
Company Description
Biofrontera
Biofrontera Inc is a biopharmaceutical company specializing in the commercialization of pharmaceutical products for the treatment of dermatological conditions, diseases caused by exposure to sunlight that result in sun damage to the skin. Its licensed products focus on the treatment of actinic keratoses, which are skin lesions that can sometimes lead to skin cancer. It also markets a topical antibiotic for the treatment of impetigo, a bacterial skin infection.
---
BFRI Stock 12 Months Forecast
Average Price Target
$16.00
▲(665.55% Upside)
Technical Analysis
---